REEV
REEV is a French medtech company developing AI-powered wearable robotics and connected gait sensors for stroke survivors and patients with neurological gait disorders, selling to US outpatient rehabilitation clinics with a planned 2026 launch of its DREEVEN robotic knee orthosis.
- Company typePrivate
- Founded2021
- HeadquartersToulouse, France
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What REEV does
REEV is a French medical robotics company founded in 2021 that develops wearable robotic and AI-powered devices for individuals with neurological gait disorders, primarily stroke survivors. The company's commercial product, REEV SENSE, is a connected sensor system (two magnetic-mounted sensors that attach to a patient's shoe or leg) paired with a mobile application that delivers clinically validated gait analysis at 95% precision compared to gold-standard motion capture labs and supports physical-therapy billing under CPT 97750. Its investigational product, DREEVEN, is an AI-powered robotic knee orthosis that uses electro-hydraulic actuation adapted from automotive and aerospace applications and proprietary real-time gait algorithms to deliver personalized knee assistance during walking, stair climbing, and standing.
REEV monetizes primarily through hardware sales of REEV SENSE on a quote-based monthly subscription (with 30-day free trials for qualified physical therapists) to outpatient rehabilitation clinics, and plans to add DREEVEN sales pending FDA clearance, with Medicare HCPCS L-Code reimbursement eligibility. The company pursues a direct sales-led GTM motion targeting outpatient clinics and rehabilitation centers in the US first, with a Neuro-Integration Program partnership channel through Stroke Centers of Excellence to prime DREEVEN adoption. Named clinical and research partners include Brooks Rehabilitation, Sheltering Arms, Good Shepherd Rehabilitation, Jefferson Health, Community Medical Centers, Emory University, and UNC Health.
The company is headquartered in Labège near Toulouse, France (with R&D in Toulouse), operates a US regional headquarters in Boston, and is led by CEO Amaury Ciurana (relocated to Boston in 2023), CTO Robin Temporelli (formerly Airbus/Safran), and Clinical Lead Dr. Lou Awad of Boston University. REEV has raised approximately €12M total across a 2023 €3M seed and a February 2025 €8.8M Series A led by Newfund Heka, Polytechnique Ventures, and Irdi Capital.
REEV firmographics
Firmographics- Name
- REEV
- Legal name
- REEV SAS
- Website
- https://reev.care
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- REEV is a French medtech company developing AI-powered wearable robotics and connected gait sensors for stroke survivors and patients with neurological gait disorders, selling to US outpatient rehabilitation clinics with a planned 2026 launch of its DREEVEN robotic knee orthosis.
- Ownership category
- akta.pro rank
REEV industry classification
Industry- Product category
- Wearable Medical Robotics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Healthcare & Assistive Robotics (HDAAAIAC)
- akta.pro secondary industries
- Mobility Aids (Wheelchairs, Scooters, Walkers, Canes) (HLAHAMAA), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
Keywords
Where REEV is headquartered
LocationHeadquarters
- HQ city
- Toulouse
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
REEV business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- REEV SENSE Gait Analysis System: Sale of wearable motion sensor systems to healthcare professionals for gait analysis. The system includes sensors, mobile app, and centralized platform for mobility assessment. Clinically validated sensors deliver precise gait insights in minutes for outpatient clinics and rehabilitation centers.
- DREEVEN Motorized Knee Brace: Sale of AI-powered robotic knee orthosis for patients with gait disorders. Custom-made for each patient, this motorized orthosis provides personalized knee assistance. Planned 2026 product launch with Medicare HCPCS L-Code eligibility.
- CPT 97750 Billing Support: REEV SENSE supports physical therapists in billing for CPT 97750 (Physical Performance Test or Measurement), enabling clinics to generate revenue by billing for objective gait assessments with SENSE reports.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | REEV SENSE - Quote-based pricing for gait analysis sensors |
| One time/ perpetual license | Multi-year contract | DREEVEN - Pricing to be determined at 2026 launch |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
REEV product offering
Product offeringCore offering
REEV sells two integrated medical wearable devices for mobility care: REEV SENSE, a connected sensor system that attaches to a patient's shoe or leg via magnetic supports to deliver clinically validated gait analysis reports to physical therapists via a mobile app; and DREEVEN, an AI-powered robotic knee orthosis using electro-hydraulic actuation to provide personalized motorized knee assistance for stroke survivors and others with neurological gait disorders. The products work together as a platform in which SENSE gait data customizes DREEVEN motor control for each patient.
Product overview
REEV offers a dual-product portfolio combining wearable robotics and AI-powered gait analysis for mobility rehabilitation. The core offering consists of DREEVEN, an AI-powered motorized knee orthosis for mobility assistance, paired with REEV SENSE, a connected sensor system for clinical gait analysis. These products work in an integrated workflow: REEV SENSE captures and analyzes patient gait data, which is then used to personalize DREEVEN's motor control and assistance for each patient's unique gait signature. The platform targets physical therapists, rehabilitation clinics, and patients with gait disorders including stroke survivors, individuals with multiple sclerosis, and those with neurological mobility impairments.
Differentiator
Problem solved
Functional benefit
Brands
- DREEVEN: AI-powered robotic knee orthosis designed for stroke survivors to regain safe, independent everyday mobility beyond the clinic. Uses ultra-precision hydraulic actuation and real-time gait sensing.
- REEV SENSE
Products and services
- REEV SENSE Advanced connected sensor system with cutting-edge motion analysis algorithms delivering precise, clinically meaningful gait insights for healthcare professionals. Two smart sensors attach to a patient's shoe or leg via magnetic supports to capture spatio-temporal and kinematics data, presenting gait biomarkers via an intuitive mobile application. Clinically validated at 95% precision for spatio-temporal analysis and less than 5° Mean Absolute Error for kinematics compared to motion capture labs. Supports CPT 97750 billing for physical therapists.
- DREEVEN First AI-powered robotic knee orthosis designed for everyday life use by stroke survivors. Uses ultra-precision hydraulic actuation and real-time gait sensing to continuously adapt support to the user's walking pattern, turning passive orthotics into intelligent wearable robotic systems. Supports up to 290 lb (132 kg) patient weight, 11 lb (5 kg) device weight, and up to 2 steps per second walking pace. Custom-made for each patient and integrated with REEV SENSE gait signature data for personalized motor control.
Quantifiable outcome
- 95% precision in gait analysis compared to motion capture labs
- +4 more outcomes
Companies that use REEV
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles2 records
REEV technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
REEV partnerships and signals
Strategic signalScale indicators13 records
Recent moves6 records
Expansion highlights5 records
REEV competitors and assessment
Company assessmentDirect peers
- Ekso Bionics: Ekso Bionics develops wearable robotic exoskeletons for clinical rehabilitation and industrial use, including the EksoNR for stroke and acquired brain injury gait training. Directly competes with REEV DREEVEN in robotic-assisted mobility for stroke survivors and shares the clinic-focused rehabilitation customer base.
- ReWalk Robotics: ReWalk Robotics produces FDA-cleared wearable exoskeletons for spinal cord injury and stroke rehabilitation, targeting similar stroke and gait-disorder patient populations as REEV. Direct peer in powered orthotic/exoskeleton category with overlapping clinical positioning.
- Hocoma: Hocoma (part of DIH Medical) is a global leader in robotic rehabilitation therapy devices including Lokomat (gait) and Armeo (upper extremity), serving the same physical therapy and rehabilitation clinic customers as REEV. Closest direct peer in robotic rehabilitation technology category.
- Bioness: Bioness develops neurostimulation and rehabilitation devices (L300 Go, BITS) for foot drop and gait dysfunction following stroke. Targets the same outpatient rehabilitation and stroke recovery market as REEV SENSE and DREEVEN.
- Myomo: Myomo develops myoelectric arm and hand orthoses that use AI/EMG sensing to assist patient movement, sharing REEV's wearable robotics + AI personalization approach. Targets stroke and neurological impairment patients with insurance-covered orthotic devices.
- CYBERDYNE: CYBERDYNE develops the HAL (Hybrid Assistive Limb) robotic suit for gait assistance and rehabilitation in stroke, spinal cord injury, and other neuromuscular conditions. Closest international peer to REEV's wearable robotic orthosis for daily-life mobility.
Broad incumbents
- Ottobock: Ottobock is the global leader in orthotics, prosthetics, and mobility aids including E-MAG active knee orthosis. While not AI-powered or robotic at REEV's level, Ottobock dominates the orthotics DME category that DREEVEN targets and is also REEV's seed-round investor's portfolio adjacency (Thuasne is the seed investor).
- Parker Hannifin (Indego): Parker Hannifin's Indego is a modular powered exoskeleton for spinal cord injury and stroke rehabilitation with FDA clearance. Direct competitor in the powered orthosis/exoskeleton category, backed by a large industrial conglomerate with deep commercialization resources.
Regional players
- Thuasne: Thuasne is a French orthopedic and medical device manufacturer that partnered with REEV during its 2023 seed round to industrialize robotic knee support products. A regional incumbent in orthotics with strong European distribution that is also a strategic partner rather than pure competitor.
Emerging players
- Wearable Robotics: Italian startup developing wearable robotic exoskeletons for industrial and medical use, including lower-limb assistive devices. Comparable emerging-stage peer with overlapping AI-actuated orthosis technology approach and European origin similar to REEV.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
REEV social profiles
Digital presenceREEV compliance and trust
Trust signalCompliance5 records
REEV financial estimates
Financial estimateRevenue estimate
Valuation estimate
REEV leadership team
Management profileNumber of profiles
Profiles3 records
REEV funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
REEV M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about REEV
What does REEV do?
REEV sells two integrated medical wearable devices for mobility care: REEV SENSE, a connected sensor system that attaches to a patient's shoe or leg via magnetic supports to deliver clinically validated gait analysis reports to physical therapists via a mobile app; and DREEVEN, an AI-powered robotic knee orthosis using electro-hydraulic actuation to provide personalized motorized knee assistance for stroke survivors and others with neurological gait disorders. The products work together as a platform in which SENSE gait data customizes DREEVEN motor control for each patient.
Is REEV a public or private company?
REEV is a private company. It is classified as venture growth investor backed and is currently operating.
When was REEV founded?
REEV was founded in 2021. It employs 11 to 50 people.
Where is REEV based?
REEV is headquartered in Toulouse, France, in the Europe region.
How does REEV make money?
Three revenue lines are on record. REEV SENSE Gait Analysis System is the primary driver. The others are DREEVEN Motorized Knee Brace and CPT 97750 Billing Support.
Who are REEV's main competitors?
Direct peers on record are Ekso Bionics, ReWalk Robotics, Hocoma, Bioness, Myomo and CYBERDYNE. Broad incumbents are Ottobock and Parker Hannifin (Indego). Thuasne is listed as a regional player. Wearable Robotics is listed as an emerging player.
Does REEV have an API?
No public API is recorded for REEV.
What industry is REEV in?
REEV's product category is Wearable Medical Robotics. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAA, Mobility Aids (Wheelchairs, Scooters, Walkers, Canes). Its NAICS code is 334510 and its SIC code is 3842.